5:32 PM
Jun 05, 2013
 |  BC Extra  |  Politics & Policy

Amendment could ease AMNOG comparator rules

The lower house of German Parliament (Bundestag) will vote Thursday on a bill that includes an amendment that would eliminate the requirement for Germany's Federal Joint Committee (G-BA) to conduct benefit assessments of new therapies vs. the lowest-cost alternative. The amendment states that additional benefit could be demonstrated...

Read the full 216 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >